Drug discovery

#AI / data analytics / healthtech / informatics #Drug discovery #eBook #Multi-omics

Omics-driven drug discovery

One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from an individual participant’s biological sample, can provide a more holistic view of the molecular factors… Read More

#eBooks #Resources

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

New DDW Highlights podcast: 26 August 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. The news this week has emphasised the importance of shared knowledge and expertise to the… Read More

#News

Digital technology concept
#Artificial intelligence (AI) #Computational chemistry #Digital workflow #Drug discovery #Machine learning #Webinar

Webinar: AI and digital workflows reshape pharmaceutical R&D

A new FREE TO ATTEND webinar ‘Transforming drug discovery with AI and digital labs‘, hosted by DDW and supported by Sapio Sciences, is now open for registrations. On 15 September at 4pm BST, join Dr Rajesh Kumar, Senior Director of Structural Biology at Schrödinger, as he explores how advanced computational… Read More

Webinar date:
Supported by Sapio Sciences
#News

#Artificial intelligence (AI) #Clinical trial design #Clinical trials #Drug discovery

The next generation of clinical trials with AI

Niven R Narain, President and CEO, BPGbio, looks at how biology-first Bayesian causal AI is redefining success in drug development. From using AI-based computational modelling to phase out animal testing for monoclonal antibodies1, to deploying its proprietary large language model-powered tool, Elsa, to read, write, and summarise regulatory documents—reducing review time… Read More

#Exclusive Content

#Drug discovery

Ebook: Omics-driven drug discovery

One of the givens of modern medicine is that a more profound understanding of the molecular complexity of disease processes will lead to more precise, personalised treatment options. Multiomics, integrating multiple types of data from an individual participant’s biological sample, can provide a more holistic view of the molecular factors… Read More

#eBooks

#Collaboration #Drug discovery #Mergers and acquisitions #Partnership

This week in drug discovery (18-22 August) 

News round-up for 18-22 August by DDW Senior Digital Content Editor Diana Turner. The news this week has emphasised the importance of shared knowledge and expertise to the development of new drugs, whether that is through research collaboration agreements or mergers and acquisitions, with a number of new… Read More

#News

#Cell analysis #Drug discovery #Guide #Imaging #Spatial biology

Accelerate your imaging research with the updated protocols guide

The second edition of the ‘Imaging protocol handbook‘ from Thermo Fisher Scientific is now available to download for free. This handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The Guide covers main procedural steps to achieve your best results. Plan and… Read More

#News

#Cell analysis #Drug discovery #Imaging #Spatial biology

Imaging protocol handbook

This imaging protocol handbook will help you accelerate your research by helping you plan and execute your imaging experiments. The Guide covers main procedural steps to achieve your best results. Plan and optimise imaging experiments with clear, step-by-step procedural guidance. Master core and advanced techniques—from cell proliferation and immunolabeling to… Read More

#Resources

#Cell Science #Drug discovery #Genetics / genomics #Spatial biology

3D spatial biology: A new dimension for drug discovery

Dr Todd Dickinson, CEO, Stellaromics on 3D spatial biology and functional genomics. Understanding how genes are regulated and expressed in complex tissue environments is fundamental to modern drug discovery. Traditionally, researchers have relied on 2D spatial genomics methods, analysing thin slices of tissue on a single plane to study gene… Read More

#Exclusive Content

#Assays #Drug discovery #Imaging #Live cell analysis #Macrophages #Phenotyping #Technical Note

Optimise macrophage assays and boost immunology research

A new free resource from Lonza is now available entitled ‘Optimising macrophage polarisation and phagocytosis assays‘. Download this Technical Note to learn: Streamlined Macrophage Workflow: Transform cryopreserved or PBMC-derived monocytes into M1 or M2 macrophages using a reproducible, high-throughput protocol. Comprehensive Validation: Confirm phenotype and function with live-cell imaging… Read More

#News

#Assays #Drug discovery #Imaging #Live cell analysis #Macrophages #Phenotyping

Optimising macrophage polarisation and phagocytosis assays

Download this Technical Note to learn: Streamlined Macrophage Workflow: Transform cryopreserved or PBMC-derived monocytes into M1 or M2 macrophages using a reproducible, high-throughput protocol. Comprehensive Validation: Confirm phenotype and function with live-cell imaging and phagocytosis assays for application-ready results. Accelerated Research: Enhance drug discovery, immunotoxicology, and screening workflows with both… Read More

#Resources

Human cell
#10x Genomics #Drug discovery #Mergers and acquisitions #Scale Biosciences #Single-cell analysis

10x Genomics expands single cell analysis with Scale buyout

10x Genomics has acquired Scale Biosciences, gaining key inventions and technologies and broadening access to single cell analysis.  Scale Biosciences was founded by a multidisciplinary team of scientists and technologists with expertise in next generation sequencing, genomics, and bioinformatics: Professor Garry Nolan at Stanford University, Professors Jay Shendure and Cole… Read More

#Business & Investment #News

#Drug discovery #Genetics / genomics #Synthetic biology #Synthetic DNA

Enzymatic DNA synthesis: Moving beyond limits

Dr Thomas Ybert, Co-founder and Chief Scientific Officer at DNA Script, describes how recent advancements in enzymatic DNA synthesis are unlocking previously inaccessible regions of the genome. Synthetic nucleic acids are foundational tools in biological research and therapeutic development, essential for applications ranging from gene synthesis to mRNA vaccine templates. Read More

#Exclusive Content

#Cell analysis #Drug discovery #Flow Cytometry #Guide #Sample preparation

Guide: Flow cytometry protocols and practical insights

Accelerate your research to help you plan and set up your flow cytometry experiments with this new free resource from Thermo Fisher Scientific. This Guide ‘Flow cytometry protocols’ covers the main procedural steps below to achieve your best results. Protocols included: Sample preparation Immune cell stimulation Phenotypic analysis Cell viability… Read More

#News

#Cell analysis #Drug discovery #Flow Cytometry #Sample preparation

Flow cytometry protocols, practical insights, application data, and more

Accelerate your research to help you plan and set up your flow cytometry experiments. This Guide covers the main procedural steps below to achieve your best results. Protocols included: Sample preparation Immune cell stimulation Phenotypic analysis Cell viability and apoptosis Cell cycle Cell proliferation… Read More

#Resources

Blood samples
#Biobanking #Drug discovery #Genetics / genomics #UK Biobank

The current state of biobanking

DDW Editor Reece Armstrong looks at the challenges and opportunities for biobanking in drug discovery. The biobanking market was worth $81.29 billion in 2024 according to GrandView Research1 and is expected to reach $126.7 billion by 2030. A legacy sector for life sciences, biobanks have acted as repositories for research… Read More

#Exclusive Content